Biglycan
| GO Term |
|---|
| extracellular region |
| extracellular matrix |
| collagen-containing extracellular matrix |
| cell surface |
| sarcolemma |
| transport vesicle |
| GO Term |
|---|
| bone development |
| articular cartilage development |
| GO Term |
|---|
| glycosaminoglycan binding |
| cytokine binding |
| extracellular matrix binding |
| Position | Description | PubMed ID | GlyTouCan ID | Source |
|---|---|---|---|---|
| 42 | O-linked (Xyl...) (glycosaminoglycan) serine |
|
||
| 48 | O-linked (Xyl...) (glycosaminoglycan) serine |
|
||
| 271 | N-linked (GlcNAc...) asparagine | |||
| 312 | N-linked (GlcNAc...) asparagine |
| Pathway Name | Organism |
|---|---|
| A tetrasaccharide linker sequence is required for GAG synthesis | Mus musculus |
| CS/DS degradation | Mus musculus |
| Chondroitin sulfate biosynthesis | Mus musculus |
| Dermatan sulfate biosynthesis | Mus musculus |
| ECM proteoglycans | Mus musculus |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.4.0
Last updated: December 8, 2025